NCT03442465 Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
| NCT ID | NCT03442465 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Bone Sarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2018-02-14 |
| Primary Completion | 2027-02-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2018-02-14 with a primary completion date of 2027-02-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who have tumor surgery plus regenerative osseous surgery. The study will look at the level of function for a period of 3 years after the surgery. Another purpose of this study is to look at how well the bone heals in participants undergoing regenerative surgery
Eligibility Criteria
Inclusion Criteria: * All patients undergoing reconstructive surgery for neoplasms involving bone on the orthopaedic surgery service at MSK * Current or prior history of primary neoplasms involving osseous structures, including all subtypes * Confirmation of diagnosis that has been performed by the MSK's Department of Pathology via direct review of tissue/slides * Patients must read and understand English * Age \>/=4 * Patients must read and understand English Exclusion Criteria: * Patients that weight \<17 kilograms
Contact & Investigator
Daniel Prince, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT03442465 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, studying Bone Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03442465 currently recruiting?
Yes, NCT03442465 is actively recruiting participants. Contact the research team at princed@mskcc.org for enrollment information.
Where is the NCT03442465 trial being conducted?
This trial is being conducted at Basking Ridge, United States, Middletown, United States, Harrison, United States, New York, United States and 1 additional location.
Who is sponsoring the NCT03442465 clinical trial?
NCT03442465 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Daniel Prince, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 300 participants.